Spides, please elaborate. What do you mean when you say the "o/s R&D for Matmor is linked to final MPA due at end of this year" ?
Do you mean an overseas ruling which would enable expenses incurred in India to be claimed in OZ? and how does a commercial relationship (i.e. an agreement) affect the R&D claim? Will the rebate have to be returned when the plant is in production? You seem to be an expert on these things. I am just a retired industrial chemist who knows "stuff" and I question the basis of some of your posts.
Ann: Results of Meeting, page-16
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ECT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.001(20.0%) |
Mkt cap ! $9.515M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.3¢ | 0.3¢ | $111 | 37.34K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 37 | 19371688 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 7684786 | 3 |
View Market Depth
| Last trade - 16.10pm 08/08/2024 (20 minute delay) ? |
| ECT (ASX) Chart |